AMW (Germany)

Basic Information

• Category: business
• Website: https://a-m-w.eu/en/

Documented Facts

• Phone: +4980244709990 (No linked source recorded for this statement.)
• Email: info@amw-pharmaceuticals.com (No linked source recorded for this statement.)

Evidence and Sources

• AMW (Germany) — Official Site (official)
• AMW (Germany) on linkedin (social)

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about AMW (Germany).

• Canonical profile: https://brandsource.ai/brands/amw-germany
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/amw-germany/json-ld
• Citation profile API: https://brandsource.ai/api/brands/amw-germany/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (84/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-22

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Dr. Serafimov is an experienced business leader with a track record of profitable growth in originator specialty drugs, generics and B2B business. He has served as Chief Business Officer of AMW since January 2024 and was appointed Managing Director in March 2026.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 1 supporting source linked.
• 2 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.